This prospective, multicenter, single-arm, open-label phase 3 study aimed to evaluate the efficacy and safety of IqYmune in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Patients received one induction dose of 2 g/kg and then seven maintenance doses of 1 g/kg at 3-week intervals. The primary endpoint was the...
-
2020 (v1)PublicationUploaded on: March 27, 2023
-
2020 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2020 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2020 (v1)Publication
Fabry disease (FD) is a systemic X-linked lysosomal disorder. A 'peripheral nerve variant' of FD has been hypothesized in subjects with neuropathy, without the early manifestations of the classic phenotype. A cohort of undiagnosed neuropathy patients with chronic polyneuropathy of undetermined aetiology and demyelinating neuropathy,...
Uploaded on: April 14, 2023 -
2021 (v1)Publication
No description
Uploaded on: March 27, 2023